Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Lifetime Data Anal. 2013 Mar 30;20(1):10.1007/s10985-013-9254-8. doi: 10.1007/s10985-013-9254-8

Table 3.

Posterior Estimates for the Panitumumab Data under FM with (J0, J1, J2) = (1, 30, 5)

Parameter EST SD 95% HPD Parameter EST SD 95% HPD
E Model
 TD Model
Intercept 1.512 0.989 (−0.438, 3.463)
Treatment −1.115 0.324 (−1.753, −0.484) Treatment −0.481 0.337 (−1.145, 0.175)
Age −0.010 0.014 (−0.039, 0.017) Age 0.023 0.015 (−0.008, 0.052)
bECOG01 1.987 0.346 (1.336, 2.699) bECOG01 −0.617 0.296 (−1.202, −0.034)
Rectal 0.303 0.337 (−0.342, 0.967) Rectal −0.060 0.319 (−0.696, 0.546)
Male −0.317 0.330 (−0.944, 0.342) Male −0.326 0.306 (−0.923, 0.279)
CenEastEU 0.001 0.628 (−1.171, 1.301) CenEastEU −0.308 0.638 (−1.545, 0.951)
WesternEU 0.334 0.422 (−0.498, 1.149) WesternEU 0.231 0.395 (−0.546, 0.991)
TE Model
 TG Model
Treatment −1.443 0.150 (−1.733, −1.148) Treatment −0.975 0.265 (−1.479, −0.441)
Age −0.019 0.006 (−0.031, −0.007) V*(1-Treatment) −1.475 0.256 (−1.968, −0.962)
bECOG01 −0.869 0.220 (−1.297, −0.431) PR Age −0.007 0.007 (−0.020, 0.006)
Rectal −0.112 0.133 (−0.379, 0.138) BTR PR −0.254 0.347 (−0.942, 0.413)
Male −0.129 0.132 (−0.386, 0.131) BTR SD −0.088 0.192 (−0.460, 0.296)
CenEastEU 0.190 0.274 (−0.351, 0.727) bECOG01 −0.445 0.242 (−0.908, 0.034)
WesternEU −0.074 0.188 (−0.446, 0.286) LECOG01 −1.186 0.177 (−1.522, −0.829)
AE 0.348 0.141 (0.082, 0.631)
τ 0.322 0.083 (0.163, 0.490)